Millennium Management LLC Purchases New Position in Mesa Laboratories, Inc. (MLAB)

Millennium Management LLC purchased a new position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 18,418 shares of the medical instruments supplier’s stock, valued at approximately $3,888,000.

Several other institutional investors have also recently added to or reduced their stakes in MLAB. Virtu Financial LLC acquired a new stake in shares of Mesa Laboratories in the second quarter worth approximately $248,000. Paloma Partners Management Co acquired a new stake in shares of Mesa Laboratories in the second quarter worth approximately $284,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Mesa Laboratories in the second quarter worth approximately $298,000. Engineers Gate Manager LP acquired a new stake in shares of Mesa Laboratories in the second quarter worth approximately $324,000. Finally, Spark Investment Management LLC acquired a new stake in shares of Mesa Laboratories in the second quarter worth approximately $337,000. 71.91% of the stock is currently owned by institutional investors.

MLAB has been the topic of several research analyst reports. TheStreet raised shares of Mesa Laboratories from a “c” rating to a “b” rating in a research report on Thursday, June 28th. Zacks Investment Research raised shares of Mesa Laboratories from a “hold” rating to a “buy” rating and set a $248.00 target price on the stock in a research report on Wednesday, July 11th. BidaskClub cut shares of Mesa Laboratories from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 18th. Finally, ValuEngine cut shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research report on Thursday, October 4th.

MLAB opened at $180.01 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.55 and a current ratio of 2.10. Mesa Laboratories, Inc. has a 1 year low of $122.35 and a 1 year high of $224.95. The company has a market capitalization of $714.78 million, a P/E ratio of 29.13 and a beta of 0.24.

Mesa Laboratories (NASDAQ:MLAB) last released its earnings results on Tuesday, July 31st. The medical instruments supplier reported $1.06 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.79 by $0.27. Mesa Laboratories had a negative net margin of 0.25% and a positive return on equity of 15.92%. The business had revenue of $25.14 million for the quarter. As a group, equities research analysts anticipate that Mesa Laboratories, Inc. will post 7.09 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, December 17th. Investors of record on Friday, November 30th will be given a $0.16 dividend. The ex-dividend date is Thursday, November 29th. This represents a $0.64 annualized dividend and a dividend yield of 0.36%. Mesa Laboratories’s dividend payout ratio is presently 10.36%.

In other Mesa Laboratories news, CFO John Sakys sold 1,000 shares of Mesa Laboratories stock in a transaction that occurred on Wednesday, August 15th. The shares were sold at an average price of $203.50, for a total transaction of $203,500.00. Following the transaction, the chief financial officer now directly owns 3,500 shares of the company’s stock, valued at $712,250. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director David M. Kelly sold 700 shares of Mesa Laboratories stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $190.01, for a total transaction of $133,007.00. Following the transaction, the director now directly owns 3,600 shares in the company, valued at $684,036. The disclosure for this sale can be found here. Insiders sold 4,400 shares of company stock worth $864,060 over the last three months. Corporate insiders own 15.00% of the company’s stock.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.

Recommended Story: Insider Trading – What You Need to Know

Want to see what other hedge funds are holding MLAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mesa Laboratories, Inc. (NASDAQ:MLAB).

Institutional Ownership by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply